4//SEC Filing
Pfeiffenberger Brent 4
Accession 0001062993-24-006667
CIK 0001850119other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:48 PM ET
Size
10.7 KB
Accession
0001062993-24-006667
Insider Transaction Report
Form 4
Pfeiffenberger Brent
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-03-07+17,425→ 1,470,704 total - Award
Stock Option (right to buy)
2024-03-07+104,550→ 104,550 totalExercise: $5.32Exp: 2034-03-07→ Common Stock (104,550 underlying)
Footnotes (3)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
- [F2]This Form 4 was originally filed under the incorrect Issuer on March 11, 2024 due to an administrative error (the "Original Form 4"). The Original Form 4 is being refiled to appear associated with the correct Issuer.
- [F3]The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0002001162
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:48 PM ET
- Size
- 10.7 KB